Enliven Therapeutics Inc (ELVN)

Date: O: H: L: C: Vol:

Enliven Therapeutics Inc Stock (ELVN) Forecast

The Enliven Therapeutics Inc (ELVN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $42.30, representing a -5.12% decrease from the current price of $44.58. The highest analyst price target is $44.03, and the lowest is $40.56.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month ELVN Price Target

Average 41.56 (-6.77% Downside)

Is Enliven Therapeutics Inc (ELVN) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	52.32	Neutral
STOCH(9,6)	84.97	Sell
STOCHRSI(14)	94.04	Sell
MACD(12,26)	-0.80	Buy
ADX(14)	31.12	Sell
William %R	-14.47	Sell
CCI(14)	65.01	Neutral

Buy: 1 · Sell: 4 · Neutral: 2Summary: Sell

Moving Averages

Period	Simple	Exponential
MA10	43.04 Buy	43.28 Buy
MA20	41.54 Buy	43.33 Buy
MA50	48.40 Sell	46.28 Sell
MA100	50.61 Sell	46.85 Sell
MA200	42.83 Buy	42.27 Buy

Buy: 6 · Sell: 4 · Neutral: 0Summary: Buy

According to our latest analysis, ELVN could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ELVN, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 52.32 indicates that ELVN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 84.97 indicates that ELVN is overbought. This means that ELVN price is at or near the highest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 94.04 indicates that ELVN is overbought. This suggests that ELVN price is at or near the highest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 31.12 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of 65.01 indicates that ELVN is still overbought but not to an extreme extent.

Long-term ELVN price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Enliven Therapeutics Inc financial reports and earnings history, Enliven Therapeutics Inc (ELVN) stock could reach $104.54 by 2030, $157.41 by 2040 and $305.59 by 2050. See the projected annual prices until 2050 of the Enliven Therapeutics Inc stock below:

Enliven Therapeutics Inc (ELVN) is expected to reach an average price of $97.34 in 2035, with a high prediction of $98.95 and a low estimate of $84.99. This indicates an +118.35% change from the last recorded price of $44.58.
Enliven Therapeutics Inc (ELVN) stock is projected to chart a bullish course in 2040, with an average price target of $153.23, representing an +243.72% change from its current level. The forecast ranges from a conservative $118.91 to a sky-high $157.41.
Our analysts predict Enliven Therapeutics Inc (ELVN) to change +357.65% by 2045, soaring from $183.74 to an average price of $204.02, potentially reaching $205.37. While $183.74 is the low estimate, the potential upside is significant.
Enliven Therapeutics Inc (ELVN) stock is expected to climb by 2050, reaching an average of $304.69, a +583.46% change from its current level. However, a wide range of estimates exists, with high and low targets of $305.59 and $240.09, respectively, highlighting the market's uncertainty.

Enliven Therapeutics Inc Stock (ELVN) Year by Year Forecast

Enliven Therapeutics Inc Stock (ELVN) Price Forecast for 2026

The predicted value for Enliven Therapeutics Inc (ELVN) in 2026 is set at an average of $42.69. Estimates vary from a peak of $62.32 to a trough of $14.79, indicating an -4.23% surge from the present price of $44.58.

Month	Average	Low	High	Change from today's price
December, 2026	$42.22	$40.56	$44.03	-5.30%

Enliven Therapeutics Inc Stock (ELVN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Enliven Therapeutics Inc (ELVN) is $41.53, with a high forecast of $47.63 and a low forecast of $35.97. This indicates an -6.83% decrease from the last price of $44.58.

Month	Average	Low	High	Change from today's price
January, 2027	$44.78	$40.27	$45.35	+0.44%
February, 2027	$44.04	$42.19	$47.16	-1.20%
March, 2027	$43.08	$40.84	$44.51	-3.35%
April, 2027	$41.27	$39.59	$43.52	-7.42%
May, 2027	$38.23	$37.44	$42.11	-14.24%
June, 2027	$38.12	$37.33	$40.73	-14.49%
July, 2027	$37.26	$36.48	$39.14	-16.42%
August, 2027	$38.38	$35.97	$38.93	-13.90%
September, 2027	$40.02	$36.29	$42.40	-10.23%
October, 2027	$42.91	$38.13	$44.53	-3.75%
November, 2027	$43.69	$41.37	$45.79	-2.00%
December, 2027	$46.61	$38.93	$47.63	+4.55%

Enliven Therapeutics Inc Stock (ELVN) Price Forecast for 2028

In 2028, Enliven Therapeutics Inc (ELVN) is projected to reach an average price of $53.94, with a high projection of $61.69 and a low estimate of $44.50. This indicates an +20.99% rise from the last price of $44.58.

Month	Average	Low	High	Change from today's price
January, 2028	$45.82	$44.50	$54.43	+2.78%
February, 2028	$52.09	$45.30	$54.10	+16.84%
March, 2028	$51.16	$48.87	$53.59	+14.75%
April, 2028	$54.60	$49.54	$55.20	+22.48%
May, 2028	$51.70	$51.23	$57.84	+15.98%
June, 2028	$52.22	$51.30	$54.76	+17.14%
July, 2028	$58.82	$52.36	$58.91	+31.95%
August, 2028	$59.55	$57.53	$61.53	+33.58%
September, 2028	$56.65	$55.71	$61.69	+27.08%
October, 2028	$54.99	$54.05	$58.27	+23.35%
November, 2028	$54.50	$53.19	$58.20	+22.25%
December, 2028	$55.12	$53.63	$56.52	+23.64%

Enliven Therapeutics Inc Stock (ELVN) Price Forecast for 2029

The 2029 price forecast for Enliven Therapeutics Inc Stock (ELVN) is $56.83 on average, with a high prediction of $68.83 and a low estimate of $47.66. This represents an +27.48% increase from the previous price of $44.58.

Month	Average	Low	High	Change from today's price
January, 2029	$55.03	$53.27	$56.10	+23.44%
February, 2029	$50.87	$47.66	$56.74	+14.10%
March, 2029	$55.28	$49.95	$55.56	+23.99%
April, 2029	$56.02	$50.98	$57.92	+25.65%
May, 2029	$55.74	$53.91	$59.59	+25.04%
June, 2029	$57.29	$55.01	$60.37	+28.52%
July, 2029	$57.45	$53.83	$57.89	+28.88%
August, 2029	$55.97	$55.02	$58.11	+25.56%
September, 2029	$58.24	$55.39	$59.23	+30.64%
October, 2029	$60.00	$54.63	$62.37	+34.59%
November, 2029	$55.20	$54.96	$61.34	+23.82%
December, 2029	$64.85	$53.64	$68.83	+45.47%

Enliven Therapeutics Inc Stock (ELVN) Price Forecast for 2030

Enliven Therapeutics Inc Stock (ELVN) is expected to reach an average price of $83.52 in 2030, with a high forecast of $104.54 and a low forecast of $62.21. This signifies an +87.36% surge from the last price of $44.58.

Month	Average	Low	High	Change from today's price
January, 2030	$68.68	$62.21	$69.48	+54.06%
February, 2030	$69.11	$64.75	$70.30	+55.02%
March, 2030	$79.28	$66.57	$80.59	+77.83%
April, 2030	$81.82	$77.14	$88.91	+83.53%
May, 2030	$82.54	$79.58	$86.03	+85.14%
June, 2030	$86.50	$74.75	$88.66	+94.04%
July, 2030	$95.11	$86.52	$96.01	+113.36%
August, 2030	$101.14	$93.41	$104.54	+126.88%
September, 2030	$97.15	$96.95	$104.53	+117.93%
October, 2030	$90.21	$87.21	$98.77	+102.36%
November, 2030	$87.90	$80.40	$90.28	+97.18%
December, 2030	$62.85	$62.58	$68.63	+40.98%

Similar to ELVN